Home › Funds › Bellevue Group AG › DXCM
Bellevue Group AG position in DXCM
DEXCOM INC · Health Care
Bellevue Group AG reported holding 822,489 shares of DXCM (DEXCOM INC) in its Q2 2026 13F filing — a position valued at US$55.4M, representing 1.17% of its reported portfolio and ranking #29 among its reported holdings. Bellevue Group AG has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's DXCM position evolved
Bellevue Group AG first disclosed a stake in DXCM in Q3 2023 at 685,733 shares (US$64.0M). The position peaked in Q1 2024 at 1,221,197 shares, worth US$169.4M. Across 12 filings, Bellevue Group AG increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 822,489 shares valued at US$55.4M — an increase of 33,723 shares quarter over quarter.. Notable position changes include a 33% increase in Q4 2023 (shares rose 12% over the following quarter), a 34% increase in Q1 2024 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 685.73K | $63.98M | New |
| Q4 2023 | 914.59K | $113.49M | Add |
| Q1 2024 | 1.22M | $169.38M | Add |
| Q2 2024 | 1.27M | $143.84M | Add |
| Q3 2024 | 1.02M | $68.18M | Reduce |
| Q4 2024 | 1.05M | $81.27M | Add |
| Q1 2025 | 1.06M | $72.67M | Add |
| Q2 2025 | 860.83K | $75.14M | Reduce |
| Q3 2025 | 786.12K | $52.90M | Reduce |
| Q4 2025 | 847.40K | $56.24M | Add |
| Q1 2026 | 788.77K | $49.53M | Reduce |
| Q2 2026 | 822.49K | $55.39M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.80M sh · $996.89M · Q2 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held DXCM?
Bellevue Group AG has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Bellevue Group AG's current position in DXCM?
As of Q2 2026, Bellevue Group AG holds 822.49K shares of DXCM (DEXCOM INC), valued at $55.39M, representing 1.17% of its reported portfolio and ranking #29.
Has Bellevue Group AG been buying or selling DXCM?
In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in DXCM. The position peaked in Q1 2024 at 1.22M shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.